drugset / Trial / NCT01727128
Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment
Non-randomizedCrossoverOpen-labelBasic science
Summary
To assess pharamcokinetics, safety and tolerability of a single oral dose of BKM120 in subjects with mild, moderate and severe hepatic impairment
Timeline
- Start
- 2011-10
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buparlisib | Small molecule | — | Oral |
Indications
No indication recorded.